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The mammalian Golgi consists of hundreds of Golgi stacks interlinked to 
form a single ribbon structure in the peri‐nuclear area. During mitosis, 
the Golgi undergoes two sequential fragmentation steps to break from 
ribbon to individual stacks, then from stacks to vesicles and tubules. The 
first fragmentation step is mediated by phosphorylation of the Golgi 
matrix protein GRASP65 and it has been shown to be essential for G2‐M 
transition. To understand if the second, vesiculating step might be 
involved in mitotic progression, we looked at GM130, a Golgi matrix 
protein mitotically phosphorylated by Cdk1 and thought to be essential 
for the mitotic Golgi vesiculation. When NRK cells were treated with the 
Cdk1 inhibitor purvalanol A, Golgi vesiculation was blocked and 
organisation of the mitotic spindle was affected and mitotic progression 
was delayed. Over expression of a GFP fusion to a GM130 
phosphorylation mutant (S25A) had no apparent effect on Golgi 
vesiculation and mitotic progression.  Also, depletion of GM130 showed 
no effect on cell cycle progression. Further down, over expression of the 
mutant GM130 (S25A) in the background of the depletion showed no 
apparent defects in Golgi vesiculation or mitotic progression. Our work 
suggests while Cdk1 based phosphorylation is essential for mitotic Golgi 
vesiculation and mitotic progression, cells might have redundant 
downstream pathways that ensure that Golgi vesiculation proceeds in 




1.1 Cell division; the basis for cell multiplication and life on earth 
All living organisms have the same basic functional unit that makes them 
up; the cell. Nearly 150 years after Rudolph Virchow famously proposed 
that all cells arise from pre existing cells(Tan and Brown 2006), we have 
made great progress in furthering his theory. However, we are still in the 
dark about the finer details of the mechanism that allows a cell to 
generate daughter cells. The cell reproduces by firstly duplicating its 
contents, segregating them and then redrawing its boundaries. In the 
process, it passes though a carefully regulated cycle of events called the 
cell cycle.  
The eukaryotic cell cycle has been best studied in yeasts and mammalian 
cells. It consists of two phases, the interphase and the mitotic phase (M-
phase). The interphase in turn is made up of three phases; the first gap 
phase (G1-phase), synthesis phase (S-phase), and second gap phase 
(G2-phase). The interphase, seemingly a period of rest for the cells is 
actually a period of intense activity wherein the cell readies itself for 
division by synthesizing proteins required for growth, duplicating its 
genetic material and other organelles such as the centrosomes, the Golgi 
among others. The mitotic phase of the cell cycle is visually much more 
dynamic with the cell undergoing rapid changes in morphology. Through a 
set of well orchestrated processes, the cell segregates its chromosomes  
to opposite ends with the  physical force required for the above essential 
process being provided by one of the cytoskeletal components of the cell; 
the microtubules. The other organelles in the cell such as the centrosome, 
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the ER, the Golgi among others would now have segregated through 
distinct mechanisms. Following this, the cell undergoes a series of 
dramatic changes in its morphology that ultimately result in the division of 
the cell into two. The story ends differently depending on the cell type 
(Balasubramanian, Bi et al. 2004) but in essence, a barrier is brought in 
between the two nascent cells, and cell division is complete. 
1.2  The Golgi Apparatus 
1.2.1  Golgi structure and inheritance 
The Golgi apparatus is one of the most fascinating organelles in the 
eukaryotic cell.  Though first identified in 1898 by the Italian physician 
Camillo Golgi, many of its functions remain among the great mysteries of 
the cell. In most eukaryotic cells, the Golgi exists as a network of tubules 
and vesicles that are arranged into stacks of flattened cisternae. Newly 
synthesized proteins from the ER are received at the cis Golgi network 
(CGN), modified posttranslationally as they traverse the Golgi stack to 
reach the trans Golgi network (TGN), where they are sorted for delivery to 
their ultimate target (Mellman and Simons 1992) 
In the plant cell and also in lower animal cells, the Golgi exist as individual 
stacks that are dispersed throughout the cytoplasm. In mammalian cells 
however, the Golgi apparatus often displays a juxtanuclear or 
pericentriolar localization wherein the individual stacks of the Golgi are 
interconnected to yield a Golgi ribbon. It has previously been shown that 
the presence of the Golgi at the pericentriolar area is dependent on the 
microtubules and is mediated by the action of the Rho GTPases (Nobes 
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and Hall 1999). Perturbation of the microtubules using either a 
depolymerising agent (nocodazole) or a stabilizing agent (taxol) has 
affected Golgi structure and localization (Sandoval, Bonifacino et al. 1984; 
Turner and Tartakoff 1989; Corthesy-Theulaz, Pauloin et al. 1992; Cole, 
Sciaky et al. 1996; Thyberg and Moskalewski 1999). The pericentriolar 
localization of the Golgi apparatus in mammalian cells has led scientists to 
speculate about the possible link between the Golgi and the centrosomes, 
the Microtubule Organizing Centre of the cell (MTOC). The affinity of the 
Golgi apparatus for microtubules can be attributed to the fact that the 
microtubules tend to associate with the MTOC in a minus end directed 
manner. The localization of the Golgi apparatus at the crucial position 
could therefore be interpreted as a controlling position for monitoring and 
possibly directing a number of cellular events.  
The mechanism that ensures the inheritance of the Golgi to both the 
daughter cells appears to be cell type-dependent, and perhaps reflects 
functional requirement of Golgi during mitosis. In plants and many single-
celled organism, the Golgi is inherited as intact, individual stacks into the 
daughter cells (Nebenfuhr, Frohlick et al. 2000). However, in mammalian 
cells where protein secretion ceases during mitosis, the Golgi undergoes 
sequential fragmentations from ribbons to dispersed stacks in G2, and 
from stacks to tubules and vesicles later in metaphase. Such extensive 
fragmentation steps are believed to ensure Golgi partition to both the 
daughter cells in a precise manner (Lucocq, Pryde et al. 1987; Lucocq 




Figure 1.1. The Golgi undergoes dramatic morphological changes 
during mitosis. During prophase, the tubular connections between the 
individual Golgi stacks are lost and the Golgi ribbon is broken down into 
individual stacks that remain close to the nucleus. Between prophase and 
metaphase, the Golgi undergoes further fragmentation whereby the 
individual cisternae are converted into small ~50–70 nm vesicles, and 
larger vesicular and tubular elements. These mitotic Golgi fragments 
either exist as discrete units or they might fuse with the endoplasmic 
reticulum (ER). During telophase, the Golgi fragments fuse with each 
other to initiate the reformation of new Golgi stacks that ultimately connect 
to form a Golgi ribbon in each daughter cell. Figure reproduced from: 
(Lowe and Barr 2007) 
 
1.2.2 Golgi ribbon undergoes severing during G2 phase  
It was shown that in mammalian cells, the initial fragmentation event 
converts the intact Golgi ribbon into isolated Golgi stacks or group of 
stacks that while fragmented, remain clustered around the nucleus 
(Colanzi, Carcedo et al. 2007; Feinstein and Linstedt 2007). When this 
fragementationfragmentation step was blocked, by inhibiting the fission-
inducing protein BARS or the kinase MEK 1 (Colanzi, Carcedo et al. 2007; 
Feinstein and Linstedt 2007), the cells were arrested in G2 phase. 
Supporting this, it was shown that the fragmentation of the Golgi 
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apparatus was essential for G2/M transition and entry into mitosis 
(Sutterlin, Hsu et al. 2002).  By targeting the Golgi matrix protein 
GRASP65 using specific inhibitory peptides and antibodies, they showed 
that blocking the Golgi fragmentation process at G2 prevented cells from 
entering mitosis. However, Itit remains unknown why this initial Golgi 
fragmentation is essential for mitotic progression. It is possible that the 
fragmentation process is designed to ensure that both the daughter cells 
inherit the organelle. It is also speculated that given the proximity between 
the Golgi and the centrosome, Golgi breakdown might be required for the  
correct maturation and separation of the centrosomes as failure in this 
fragmentation might physically prevent the MTOC reorganization during 
mitosis thereby leading to mitotic failure (Colanzi and Corda 2007) 
The molecular mechanism that is behind the first Golgi fragmentation 
event has been extensively studied. The fission inducing protein BARS 
was shown to be necessary for the process although BARS on its own is 
insufficient to induce fragmentation. Subsequently it was shown that 
another Golgi matrix protein GRASP65 might also be involved. GRASP 65 
is a coiled coil protein that forms homodimers and it has been thought that 
GRASP65 dimers located on adjacent Golgi stacks could help to link them 
together to form the ribbon structure(Preisinger, KoÌˆrner et al. 2005; 
Wang, Satoh et al. 2005). GRASP65 carries out a number of different 
functions and each of them seem to be mediated by specific 
phosphorylation of specific sites.  
It has been shown that GRASP65 phosphorylation at S277 is essential for 
G2/M progression (Yoshimura, Yoshioka et al. 2005). In addition, it was 
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shown that the kinases MEK 1 and Plk1 might also be involved in the G2 
Golgi fragmentation.  
 
Table 1.1. List of kinases involved in regulating Golgi structure and 
function. Table modified from: (Lowe and Barr 2007) 
 
The effector of MEK1 on the Golgi , ERK1c was discovered and it was 
demonstrated that depletion of ERK 1c reduces Golgi fragmentation 
(Shaul and Seger 2006). The target for ERK1c is speculated to be 
GRASP55 as it  was shown to be phosphorylated by ERK1/2 at T222 or 
T225 and failure to do so delayed mitosis (Feinstein and Linstedt 2007). 
Though the multiple kinases and pathways detailed above might function 
together to mediate G2 specific Golgi fragmentation, their precise 
regulation and function remain to be identified.  
 
 
Kinases Interaction Substrates Proposed function of substrate 
 partners   
CDK1 Cyclin B GM130 Golgi membrane and vesicle tethering 
  GRASP65 Membrane tethering and cisternal stacking 
  RAB1 Golgi membrane and vesicle tethering 
  p47 Membrane fusion 
  NIR2 Phospholipid transfer 
PLK1 GRASP65 GRASP65 Membrane tethering and cisternal stacking 
 RAB1 RAB1 Golgi membrane and vesicle tethering 
PLK3 Giantin Unknown Not applicable 
 MEK1   
 ERK2   
MEK1 PLK3 Unknown Not applicable 
ERK1/2 PLK3 GRASP55 Cisternal stacking 
ERK1c Unknown Unknown Not applicable 
Unknown Unknown Golgin-84 Golgi-membrane and vesicle tethering 
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1.2.3 The mechanism of Golgi vesiculation 
1.2.3.1 The reason for Golgi vesiculation 
The reason as to why the Golgi has to undergo further fragmentation is 
not clear. Accurate Golgi inheritance is possible with the individual stacks 
generated by the initial fragmentation process and has been 
demonstrated to be the case in many organisms such as plants. The 
second fragmentation event might be essential to ensure a more accurate 
inheritance or it might also have a role in regulating mitosis by releasing 
factors that are sequestered in the Golgi during interphase. It is also 
possible that the Golgi vesiculation might have effects on influencing the 
rapid changes in the cytoskeleton that occurs during mitosis.  
The second fragmentation step of the Golgi, however, has been the 
source of  a considerable debate in the community (Shima, Haldar et al. 
1997; Shima, Cabrera-Poch et al. 1998). At the onset of mitosis, the 
isolated Golgi stacks undergo further fragmentation or vesiculation to 
produce a dispersed array of tubulovesicular clusters also known as the 
Mitotic Golgi Clusters (MGC) (Lucocq and Warren 1987; Lucocq, Berger 
et al. 1989; Warren, Levine et al. 1995; Shima, Haldar et al. 1997). The 
MGCs contains most of the Golgi resident enzymes except p115 (Lowe, 
Gonatas et al. 2000). The changes in the Golgi morphology are 
concomitant with an elevation in Cdk 1 levels. When the cell reaches 
prometaphase, the MGCs relocate and now surround the newly formed 
mitotic spindle (Shima et al. 1998, Whitehead & Rattner 1998, Jokitalo et 
al. 2001). The MGCs undergo still further separation just before 
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metaphase. Part of the MGC remains associated with the spindle while 
the other part is distributed to the cell cortex presumably by the mitotic 
spindle (Shima, Cabrera-Poch et al. 1998)  
The molecular mechanism behind the mitotic Golgi vesiculation has been 
studied. It is known that the mitotic disassembly of Golgi stacks proceeds 
via two distinct, concurrent fragmentation pathways. The first pathway 
also known as the COPI-dependent pathway proceeds because COPI 
vesicles continue to bud from the Golgi stack but due to restrictions in 
mitotic transport, they are unable to tether and fuse with their target 
membrane (Misteli &Warren 1994, Nakamura et al. 1997). This pathway is 
thought to contribute to about 65% of the mitotic Golgi vesiculation (Misteli 
and Warren 1994; Misteli and Warren 1995; SÃ¶nnichsen, Watson et al. 
1996). The second pathway which is also known as the COPI-
independent pathway converts the flattened cisternal cores into a 
heterogeneous array of tubulovesicular  elements via unknown 
mechanisms (Misteli and Warren 1995). 
1.2.3.2 The role of GM130 in COPI- dependent Golgi vesiculation 
A molecular explanation for the COPI dependent mitotic Golgi vesiculation 
has been proposed. p115 is a homodimeric vesicle-tethering protein that 
is required for  intra-Golgi (Waters, Clary et al. 1992; Seemann, Jokitalo et 
al. 2000) and ER-Golgi transport(Allan, Moyer et al. 2000; Moyer, Allan et 
al. 2001). p115 brings the Golgi membrane and the vesicle membrane 
together in interphase by binding to two Golgins, GM130 and Giantin 

















Figure 1.2. COPI vesicle tethering under interphase and mitotic 
conditions. During interphase, p115 dimers link giantin on the COPI 
vesicles to GM130 on the Golgi membrane. During mitosis, GM130 is 
phosphorylated at S25 and this precludes p115 binding to GM130 thereby 
preventing COPI vesicle tethering to the Golgi.  
 
 
GM130 and Giantin are long, rod-like fibrous proteins due to an extensive 
coiled-coil domain structure typical of Golgins (Linstedt and Hauri 1993; 
Nakamura, Rabouille et al. 1995). GM130 consists of 986 amino acids 
and has 6 coiled coil domains. It has an N terminal region that binds to 
p115. Its C terminal was shown to interact with another Golgi structural 
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protein GRASP65. Giantin, on the other hand, is present both on the Golgi 
membrane and on the surface of the COPI vesicles (Nakamura, Rabouille 
et al. 1995; SÃ¶nnichsen, Watson et al. 1996; MartÃ-nez-MenÃ¡rguez, 
Prekeris et al. 2001).  
During mitosis, the N-terminal domain of GM130, comprising the p115 
binding site, is phosphorylated on serine 25 by CDK1/Cyclin B, thereby 
inhibiting p115 binding(Nakamura, Lowe et al. 1997; Lowe, Rabouille et 
al. 1998). Although p115 can still bind Giantin, it is no longer able to 
cross-link to GM130. As a result, COPI vesicles accumulate, as they are 
unable to tether and fuse, and intra-Golgi transport is inhibited (Collins 
and Warren 1992; Stuart, Mackay et al. 1993). 
Supporting this, GM130 was shown to be phosphorylated in vivo during 
prophase at the onset of Golgi fragmentation, using an antibody that 
specifically recognizes pS25 GM130 (Lowe, Gonatas et al. 2000). GM130 
remains phosphorylated until telophase, when it is dephosphorylated. 
GM130 phosphorylation and dephosphorylation is synchronous with p115 
dissociation and reassociation with Golgi membranes in addition to Golgi 
fragmentation and reassembly (Lowe, Gonatas et al. 2000).  
More recently, it was shown that depletion of GM130 in HeLa cells causes 
centrosomal and spindle abnormalities (Kodani and SuÌˆtterlin 2008). 
Hence GM130 appears to play a major role in linking the Golgi structureal 
dynamics to the progression of mitosis. Based on the above model that 
has been proposed to explain GM130 mediated Golgi vesiculation, the 
use of a phosphorylation deficient mutant (S25A) is an ideal method to 
perturb the vesiculation process and observe the effects on mitotic 
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progression. The lack of a phosphorylation site at S25 will presumably 
allow the COPI vesicles to continue to dock and fuse with the Golgi 
























2. Materials and Methods 
2.1 Cell line 
The cell line used in the study is the adherent Normal Rat Kidney 
Epithelial (NRK) cells usually designated as NRK-52E.  
   
2.2 Reagents 
2.2.1  Solutions 
0.05% trypsin (See appendix for composition) 
STE (See appendix for composition) 
  
2.2.2 Drugs 
The Cdk inhibitor purvalanol A (Tocris Bioscience) used in this study was 
stored as 15mM aliquots at -200C and the working concentration was 15 
uM. Purvalanol A was shown to act as a competitive inhibitor of ATP 
binding to Cdk (Villerbu, Gaben et al. 2002). 
2.2.3  Antibodies    
The primary and secondary antibodies used in this study are listed in 






Table 2.1A: Primary antibodies used in this study 









Warren PFA 1:1000 
 
pS25 GM130 Santa Cruz PFA 1:50 
 
 










Product Source Fixation Dilution 
Anti-mouse conjugated 





















2.3   Cell culture 
2.3.1 Culture conditions 
NRK cells were maintained in Kaighn’s modified F12 (F12K; Sigma) 
medium supplemented with 10% FBS, 1 mM L-glutamine, 100 U/ml 
penicillin, and 100 µg/ml streptomycin (GIBCO) at 37°C and 5% CO2. 
Cells were maintained on 100 or 60 mm culture dishes.  For microscopic 
imaging, cells were cultured on a custom made 35mm glass chamber as 
described previously (Mckenna and Wang, 1989).  Briefly, a 35 mm hole 
was drilled through a plate of acrylic plastic.  A layer of vacuum grease 
was then laid around the hole and the plate was autoclaved.  The hole 
was then covered by a sterilized large glass cover slip to form a culture 
chamber.   
To subculture, cells were rinsed with STE (~5 ml for 100 mm dish and ~2 
ml for 60 mm dish) briefly.  Cells were then treated with 2 ml of 0.05% 
trypsin for 1-5 minutes at room temperature.  When the majority of cells 
were seen to have detached from the culture dish, the complete medium 
was added and cells were vigorously detached.   An appropriate number 








2.4  Molecular biology 
2.4.1 E.coli strain used and plasmid amplification strategy 
 
The E.coli XL1 Blue was used for maintenance and amplification of the 
plasmids.  Electrocompetent XL1-Blue cells were transformed with 200-
500 ng of the individual plasmid using MicroPulser Electroporator (Bio-
Rad Laboratories, Hercules, CA, USA) at 2.5 V. The cells were then 
recovered in Super Optimal broth with Catabolite repression (SOC) for 1hr 
at 37˚C with shaking at 250 revolutions per minute (rpm) in Unitron-Plus 
incubator shaker (Infors, Bottmingen, Switzerland), and incubated on 
Luria-Bertani Broth (LB) agar containing appropriate concentration of the 
antibiotic for antibiotic selection for 14 hrs at 37 ˚C in MIR-262 incubator 
(SANYO Biomedical, Wood Dale, IL, USA). Resultant colonies were 
picked and cultured in 2×yeast extract tryptone (YT) medium containing 
appropriate concentration of the antibiotic for 14 hrs at 37 ˚C with shaking 
at 250 rpm in Unitron-Plus incubator shaker. Purification of plasmid DNA 
was performed using either High-Speed Plasmid Mini Kit (Geneaid, 
Taiwan) or QIAprep Spin Miniprep Kit (QIAGEN) and plasmid Maxiprep kit 
(QIAGEN) according to manufacturers’ instructions. 
 
2.4.2 Plasmid construction 
pCDNA Rat GM130 FL and GM130 S25A mutant cDNA constructs were a 
kind gift from Dr. Martin Lowe (Manchester University). The cDNA was 
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removed from the pcDNA vector using the EcoR1 and BamH1 restriction 
enzymes and cloned into the corresponding sites in pEGFP C2 vector 
(Clontech). Subsequently, PTdTomato-GM130 FL WT and S25A were 
constructed by substituting the GFP with TdTomato using the restriction 
enzymes Nhe1 and BsrG1. 
 
2.4.3 ShRNA 
SureSilencing shRNA plasmids (SABiosciences, Washington, DC.USA) 
targeting rat GM130 were purchased for the knockdown experiments. Two 
shRNA plasmids targeting rat GM130, shRNA2 -GFP and shRNA 4 –GFP 
recognizing the GM130 sequence ‘TGAGGAAGTTCAGGGCAAGAT’ and 
‘AACAACTGCAGGTTCACATT’ respectively were used. The negative 
control, shRNA NC- GFP, contained the scrambled artificial insert 
sequence ‘GGAATCTCATTCGATGCATAC ’. The GFP in the shRNA 
plasmids allowed the identification of transfected cell under the 
microscope. 
 
2.5    Plasmid transfection 
For GalT –GFP, GFP-GM130 FL and GFP-S25A mutant   over expression 
experiments, 0.5 µg of the respective plasmid was transfected into NRK 
cells using Effectene® (Qiagen, Hilden, Germany) as per the 
manufacturer’s instructions. Briefly, NRK cells at a density of 5 × 104 
cells/ml were plated in glass chambers and incubated for 24 hrs to 
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reached 40–60% confluence. Effectene reagent was diluted in F12k 
medium containing 1% FBS. The cells were transiently transfected with 
0.3-0.8 µg of plasmid DNA with Effectene in accordance to the 
manufacturer’s instruction for 6-6.5 hrs. The Effectene-DNA complex 
mixture was removed and cells were cultured for an additional of 40-42 
hrs in F12K medium supplemented with 10% FBS before live-cell imaging 
or immunofluorescence was carried out.  
For the GM130 ShRNA transfection, cells were grown on a              cover 
slip chamber to ~50% confluency and were transfected with 1 µg each of 
ShRNA2 and ShRNA 4 targeting rat GM130 using lipofectamine 2000 
transfection reagent according to manufacturer's instructions.  The cells 
were prepared for live imaging or for immunofluorescence analysis 72 
hours post transfection. 
 
2.6 Microscopy 
2.6.1 Sample preparation for live-cell imaging 
For live-cell imaging, the chamber containing the cells was overlaid with 
mineral oil (Sigma-Aldrich) to avoid evaporation of medium.  
2.6.2 Sample preparation for immunofluorescence staining 
Cells were rinsed twice with warm PBS and then fixed with either of two 
fixative reagents, 4% paraformaldehyde (EM Sciences) for 10 min at room 
temperature or 100% methanol for 10 minutes at -200C.  Cells were then 
washed with PBS three times for 5 minutes and permeabilized with 0.2% 
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Triton X-100 in PBS for 2-5 minutes.  After washing with PBS three times 
for 5 min, cells were blocked for 1 hour with 3% BSA in PBS, and then 
incubated with primary antibodies for 45-60 minutes at 37°C.  After rinsing 
three times with PBS (5-10 minutes), the cells were incubated with the 
appropriate secondary antibodies for 45 minutes at 37°C.   
 
2.6.3 Image acquisition 
For live-cell imaging, cells were maintained at 37°C in a custom made 
incubator built on top of an Axiovert 200 M inverted microscope (Carl 
Zeiss) and viewed with a 100×, NA1.30, Plan-NEOFLUAR lens.  All 
images were acquired with cooled charge - coupled device camera 
(CoolSNAPHQ, Roper Scientific) using MetaView imaging software 
(Universal Imaging). Immunofluorescence stained samples were 
visualized using either the Axiovert 200 M inverted microscope (100×, 
NA1.30, Plan-NEOFLUAR lens) or a LSM 510 Meta inverted confocal 
microscope system (100×, NA 1.25 Achroplan lens or a 100×, NA 1.4 
Plan-Apochromat lens).   
 
2.6.4 Image analysis 
2.6.4.1 Quantification of fluorescence intensity 
Fluorescence intensity was measured with MetaMorph (Universal 
Imaging) and ImageJ (NIH) software. Briefly, the z stacks obtained at 
different time points were subjected to sum slice intensity projection along 
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the z axis. Following this, regions of interest were selected and the 
average or integrated intensities were obtained.  The intensity of the 
background was also obtained.  The results were logged into Microsoft 



















3.1 The Golgi apparatus in mammalian cells undergoes dynamic 
changes during mitosis 
The dynamics of the Golgi was observed using GFP fusions of a Golgi 
resident enzyme GalT (Galactosyltransferase) (Fig. 3.1).   It was seen that 
during the interphase, the Golgi exhibited a pericentriolar ribbon like 
architecture. In early prophase, the Golgi no longer resembled the ribbon 
structure and instead was found as disconnected masses. The Golgi 
blobs however were still able to localize to the pericentriolar region. Upon 
the onset of mitosis, the individual Golgi blobs appeared to be stable until 
nuclear envelope breakdown. Concomitant with NE breakdown, the Golgi 
blobs started disintegrating into smaller fragments. (Fig. 3.1, time 00:00).  
At metaphase (Fig. 3.1, time 08:13), the Golgi was reduced to small 














Figure 3.1 Golgi underwent dynamic changes during mitosis. Cells 
were transfected with the Golgi resident enzyme GalT (Galactosyl 
Transferase) fused to GFP and subjected to live imaging. Z stacks were 
obtained at intervals of two minutes and reconstructed using maximum 
intensity projection. During mitosis, the Golgi starts vesiculating during 
prophase and is reduced to a haze by around metaphase. Following 
chromosome segregation during anaphase, the Golgi starts reappearing 
as spots that further coalesce into larger blobs finally reforming the Golgi 
ribbon during telophase. Scale bar represents 5 μm. Time elapsed is 
shown. 
 
 After anaphase onset, when the chromosomes started separating, the 
Golgi reappeared slowly (Figure 3.1 time 17.51). At first they were seen 
as bright spots throughout the cell. Soon, these small spots started to 
coalesce and at the same time move towards the newly formed nucleus 
presumably close to the MTOC. During cytokinesis two fractions of the 
Golgi were observed on either side of the nucleus with one fraction in 
close proximity to the nascent midbody. This suggests that the 
membrane-fusion events that are necessary to complete cytokinesis are 





3.2 Purvalanol A treatment affects Golgi vesiculation and mitotic 
progression 
Our preliminary approach to perturb the Golgi vesiculation process was to 
use a Cdk 1 inhibitor. It was previously shown that the Cdk 1 inhibitor, 
purvalanol A effectively inhibited Cdk activity specifically (Villerbu, Gaben 
et al. 2002) . In our experiments, cells transiently transfected with GalT-
GFP were treated with Purvalanol A (15 µM) and immediately visualized.  
In dividing cells, we observed a dramatic change in Golgi dynamics.  The 
Golgi network though fragmented, was still able to retain its pericentriolar 
localization throughout the process of mitosis and was inherited intact to 
the daughter cells. Moreover, the cells also displayed mitotic delay and 
defects (Fig 3.2).  Most cells were unable to form a functional metaphase 
plate.  In cases where  a metaphase plate was formed, the chromosome 
congression and segregation were severely affected and the time taken to 




























Figure 3. Golgi vesiculation and mitotic progression were affected 
in cells treated with Purvalanol A. Cells were transfected with the 
Golgi resident enzyme GalT (Galactosyl Transferase) fused to GFP. The 
Cdk1 inhibitor purvalanol A was added to the cells at the concentration 
of15uM and the cells were imaged immediately. Upon purvalanol A 
treatment, the Golgi did not undergo normal mitotic dynamics. It failed to 
form the haze and instead was inherited intact to both the daughter cells. 
Not only was Golgi vesiculation blocked, but cells exhibited mitotic 
defects (Arrow indicates an unattached chromosome even after initiation 
of chromosome segregation) and delays (time elapsed is shown). Scale 
bar represents 5 μm.  
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3.3   Purvalanol A treatment abolished GM130 phosphorylation  
In order to examine whether phosphorylation of the Golgi matrix protein 
GM130 was affected by purvalanol A treatment, we analyzed the 
phosphorylation state of GM130 using an antibody that specifically 
recognized GM130 phosphorylated at S25 (Shah, Patel et al. 2005). Cells 
were grown to about 70% confluence upon when, 15 uM purvalanol A was 
added. After an incubation period of 30 minutes, the cells were processed 
for immunofluorescence. We found that treatment of cells with purvalanol 
A not only prevented golgi vesiculation as visualized by GM130 staining 
but also abolished the mitotic phosphorylation of the Golgi matrix protein 
GM130 as visualized by pS25 staining. While in control mitotic cells the 
Golgi haze was brightly stained with the pS25 GM130 antibody, this 
staining was not observed in Purvalanol A treated mitotic cells (fig3.3A 
and 3.3B). To quantify the staining at different mitotic stages, 5 cells from 
each of the different cell cycle stage were visualized and the fluorescence 
intensity was quantified (Fig. 3.3C). It was observed that the fluorescence 
intensity increased 1.5 times when control cells entered mitosis whereas 
the increase was reduced to about 0.5 fold in purvalanol A treated cells. 
The marginal increase in fluorescence in purvalanol A treated cells could 
be due to non-specific interaction of the pS25 GM130 antibody to other 














































Figure 3.3: Phosphorylation of GM130 S25 was abolished in 
Purvalanol A treated cells. Cells were either not treated (A) or treated 
(B) with 15 uM purvalanol A and fixed with 4 % PFA after 30 minutes 
and stained for GM130 and pS25 GM130 (that specifically recognizes 
phosphorylated GM130). (A) In control cells GM130 underwent 
phosphorylation during prophase and retained the phosphorylation state 





GM130 did not undergo substantial phosphorylation. The residual 
phosphorylation presumably reflects background staining (C) 
Quantification of the fluorescence intensity in control and Purvalanol A 
treated cells was performed at four different cell cycle stages and 
normalized to the interphase value. Scale bar represents 10 μm. 
 
 
3.4 Over expression of GFP-GM130 FL and GFP-GM130 S25A mutant  
did not affect Golgi dynamics 
In order to perturb mitotic Golgi vesiculation more specifically, we 
decided to focus on GM130, the target of Cdk 1 in the Golgi that was 
proposed to mediate Golgi vesiculation. To this end, we generated GFP 
fusion proteins to both the wild type and a phosphorylation deficient 
mutant (S25A) of GM130. Cells were transiently transfected with either 
GFP-GM130 FL WT or GFP-GM130 S25A and dividing cells were 
imaged (Fig 3.4). The results indicated that over expression of either 
GFP-GM130 full length or the phosphorylation deficient mutant S25A did 
not affect either Golgi vesiculation or mitotic progression (Fig. 3.4A and 
B). The Golgi exhibited normal kinetics, starting to vesiculate during 
early mitosis, forming the mitotic Golgi haze at metaphase and 
reappearing at telophase. The mitotic progression in the cells over 
expressing GM130 FL as well as the S25A mutant was analyzed and the 
duration for mitosis was comparable to control cells    (Fig 3.4A, time 




Figure 3.4: Golgi dynamics was unaffected by GM130 over 
expression. NRK cells were transfected with either (A) Full length 
GM130 or (B) S25A GM130 and followed by imaging.  In both the cases, 
it was seen that over expression of either the full length or the 
phosphorylation deficient mutant of GM130 did not affect mitotic 
progression (Time elapsed is shown). Contrary to GalT dynamics, more 
spots of GFP-GM130 persisted through mitosis and this can be 
attributed to the fact that GM130 is a matrix protein and behaves 
differently from GalT which is a Golgi resident enzyme. Scale bar 









3.5  ShRNA against GM130 successfully depleted GM130  
The over expression of GM130 S25A mutant did not have any specific 
effects on mitotic Golgi vesiculation or mitotic progression. However, there 
was a possibility that the endogenous GM130 that was still capable of 
being phosphorylated might mitigate the effect of over expression of the 
S25A mutant. In order to exclude this possibility, we depleted endogenous 
GM130, by shRNAs designed specific to rat GM130. Altogether, 4 
shRNAs (targeting 4 different regions in GM130) were tested. ShRNA2 
and shRNA4 were found to be most effective. A combination of both 
ShRNA2 and 4 was therefore used for all futher depletion experiments. 
Shown in Fig. 3.5 are representative cells transfected with ShRNA2 and 
ShRNA4 using Lipofectamine reagents. Seventy two hours after 
transfection, cells were fixed and stained for GM130. Quantification of the 
images indicated that up to 75% of the endogenous GM130 was depleted 
























Figure 3.5:  ShRNA against rat GM130 depleted endogenous GM130 
efficiently. Cells were transfected with a mixture of two ShRNA against 
two different regions of rat GM130 (GFP acts as a marker for transfection) 
and were processed for immunofluorescence 72 hours after transfection. 
(A) Cells transfected with the ShRNA showed decreased fluorescence 
intensity upon GM130 staining when compared to the non transfected 
cells. (B) GM130 sequence based on which the ShRNAs were designed 
(C) Quantification of fluorescence intensity of GM130 staining in ShRNA 




3.6   Depletion of GM130 does not affect mitotic progression 
After confirming the depletion efficiency of the ShRNA, the mitotic 
progression of cells depleted of GM130 were followed by time lapse 





shRNA4) and incubated for 72 hours after which they were imaged. The 
GM130 depleted cells were identified by the GFP signal and their mitotic 
progression was monitored.  It was found that depletion of endogenous 
GM130 did not lead to any defects in mitotic progression. The cells were 
able to segregate their chromosome normally and undergo cytokinesis in 
normal time duration as compared to control cells (36 minutes). 
Figure 3.6:  Depletion of GM130 did not affect mitotic progression. 
Cells were transfected with a mixture of 2 ShRNAs against rat GM130 and 
incubated for 72 hours after which they were imaged. Cells that were 
transfected with GM130 ShRNA showed no significant defects or delays 
in mitotic progression (n=6). Shown in the inset is the GFP to indicate 
transfected cell. Scale bar represents 5 μm. Time elapsed is shown. 
 
 
3.7 GM130 S25A over expression did not affect mitotic progression 
or Golgi vesiculation 
While depletion of GM130 did not affect mitotic progression, over 
expression of the phosphorylation deficient mutant (S25A) was 
hypothesised to induce a block in Golgi vesiculation and hence mitotic 
progression. Over expression experiments were carried out with the S25A 
mutant by co transfecting an excess of the S25A mutant along with the 
shRNA mixture. After 72 hours of incubation, cells were imaged to 
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visualize the effect of GM130 S25A over expression.  In cells over 
expressing the S25A mutant, the Golgi apparatus regained the ribbon 
architecture, indicating that the S25A mutant was indeed able to rescue 
the interphase morphology of the Golgi. However, over expression of the 
S25A mutant did not affect mitotic Golgi vesiculation or mitotic 
progression. The Golgi underwent fragmentation in G2 phase and 
subsequently underwent vesiculation as the cells progressed through 
mitosis (Fig. 3.7).  The cells proceeded through mitosis with kinetics 
similar to control cells (Fig. 3.7, time 55.10) suggesting that the over 






















Figure 3.7: Over expression of S25A GM130-tomato in cells depleted 
of Gm130 does not affect Golgi vesiculation. Cells were co transfected 
with ShRNA and Tomato-GM130 S25A and were incubated for 72 hours 
before being subjected to imaging. The cells neither showed any visible 
defects in mitotic progression nor was Golgi dynamics in these cells 




4.1  Golgi dynamics during mitosis is dependent on Cdk 1 
The Golgi breakdown during mitosis has been postulated to be a very 
important step that controls cell cycle progression. While the initial 
fragmentation step was shown to offer cells a checkpoint on which to 
decide cell cycle progression, the reason for the mitotic Golgi 
vesiculation has been the source of an intense debate for quite some 
time (Colanzi, Suetterlin et al. 2003). Though the mitotic Golgi haze has 
been reported in many different mammalian cell types, the nature of the 
haze depended on the Golgi marker used for visualization.  In this study 
we used a  Golgi resident enzyme, and found that the haze appeared 
uniform with very few bright spots representing mitotic Golgi clusters. 
However when we used a Golgi matrix protein, a far greater number of 
Golgi spots were observed. This possibly reflects the different fates of 
the Golgi constituents wherein the Golgi enzymes enter the ER and the 
Golgi matrix components remain independent of the ER (Seemann, 
Pypaert et al. 2002; Pecot and Malhotra 2004).   
The molecular mechanism behind the mitotic Golgi vesiculation has 
remained elusive. It was previously proposed that Cdk 1 acting through 
its Golgi localized target GM130 played a role in Golgi vesiculation 
(Lowe, Rabouille et al. 1998). The Cdk 1 inhibitor Purvalanol A was 
shown to inhibit Cdk 1 levels very effectively in cells (Villerbu, Gaben et 
al. 2002; Hu, Coughlin et al. 2008). Based on imaging at different 
concentrations, we decided to use 15µM of the drug to inhibit Cdk 1 
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activity. This was because purvalanol A was known to inhibit Cdk 1 and 
Cdk 2 and hence it could cause a G1 and a G2 arrest in addition to its 
inhibitory activities during mitosis. However at concentrations of 15 uM, 
the drug seemed to permit cells to enter mitosis while perturbing normal 
mitotic activity.  
In cells treated with purvalanol A, at prophase, the Golgi was observed 
to be composed of individual blobs, suggesting that Cdk 1 
phosphorylation might not be involved in the initial fragmentation process 
and that this process is mediated by other kinases as described before 
(Acharya, Mallabiabarrena et al. 1998), (Preisinger, KoÌˆrner et al. 2005).  
While the experiments with purvalanol A demonstrated the requirement 
of Cdk1 for mitotic Golgi vesiculation and mitotic progression, it is known 
that Cdk 1 controls a number of targets in the cell (Nigg 2001) and hence 
the block in mitotic Golgi vesiculation may or may not be a specific effect 
of Cdk 1 inhibition. Moreover, the efficiency of the drug seemed to wear 
off with time, with cells imaged immediately after purvalanol A treatment 
showing very strong effect compared to the cells which were imaged 
subsequently. For the above mentioned reasons, a more specific means 
to perturb mitotic Golgi vesiculation was probed. 
 
4.2 Perturbing GM130 does not modulate mitotic Golgi vesiculation 
The Golgi localized target of Cdk 1 during mitosis was then the obvious 
choice for testing our hypothesis that blocking Cdk1 based 
phosphorylation events could inhibit Golgi vesiculation and hence mitotic 
progression. The Golgi matrix protein GM130 was known to be 
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mitotically phosphorylated by Cdk 1 through biochemical experiments 
(Nakamura, Lowe et al. 1997; Lowe, Rabouille et al. 1998; Lowe, 
Gonatas et al. 2000).  However, microscopic observation of the GM130 
dynamics with and without Cdk1 based phosphorylation was not 
performed in living cells. In this study, two different variants of GM130 
fused to GFP, the full length version and the other being a 
phosphorylation deficient mutant (S25A, that was incapable of being 
mitotically regulated), were used. Over expression of the GFP- full length 
GM130 or the phosphorylation deficient mutant showed normal Golgi 
dynamics and mitotic progression with the cells capable of forming the 
characteristic Golgi haze and undergoing cytokinesis in time durations 
comparable to control cells.  
In the above mentioned over expression experiments, we could not 
exclude the possibility that the endogenous GM130 was able to carry out 
its function of promoting Golgi vesiculation even in the presence of the 
excess of the S25A mutant. This necessitated the removal of the 
endogenous GM130 from the cells. There had been many reports 
wherein depletion of GM130 was performed by using RNA interference 
(Puthenveedu, Bachert et al. 2006; Kodani and SuÌˆtterlin 2008; Rivero, 
Cardenas et al. 2009) . The experiments provided equivocal views on 
the effect of the depletion on the cells. While some reports suggested 
that depletion of GM130 affected secretion only mildly, another report 
suggested that depletion of GM130 in HeLa cells affected cell cycle 
progression severely. In our experiments, depletion of GM130 in NRK 
cells was achieved by using ShRNAs. However depletion of GM130 did 
37 
 
not have any effect on mitotic progression or Golgi vesiculation although 
the interphase Golgi architecture was affected. This was in confirmation 
with previous reports that suggested that depletion of GM130 affected 
the ribbon architecture as GM130 could have a role in both cisternae 
stacking and integration of individual Golgi stacks into a ribbon 
(Puthenveedu, Bachert et al. 2006). The fact that depletion of GM130 did 
not have any effect on Golgi fragmentation can also be explained in the 
following scheme. In interphase cells, in the absence of GM130, the 
COP I vesicles are unable to dock and fuse with the Golgi however the 
continued activity of the anterograde transport  (mediated by the COPII 
vesicles) and the ability of the COPI vesicles to fuse directly with the ER 
suggest that Golgi mediated transport is only slightly affected. During 
mitosis, the absence of GM130 resembled the mitotic phosphorylation 
state of GM130 and hence Golgi vesiculation proceeds as usual. 
Following the depletion of GM130, over expression experiments were 
performed in cells depleted of GM130 with TdTomato-S25A GM130. The 
rationale behind the rescue experiments was that depletion of GM130 
somehow resembles the mitotic phosphorylation state and hence had no 
effect on mitotic Golgi vesiculation.  Over expression of the full length 
GM130 in cells depleted of endogenous GM130 would bring the Golgi 
architecture back into equilibrium. Due to the presence of the S25 
residue, it can still be regulated mitotically. However, over expression of 
the S25A construct in cells depleted of GM130 can have drastically 
different effects for the cell. While the cell might regain the interphase 
Golgi architecture, the absence of the S25 residue will prevent mitotic 
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phosphorylation and hence will cause a block in mitotic Golgi 
vesiculation (as illustrated in figure 4.1). 
However, over expression of the S25A GM130 protein in cells depleted 




Figure 4.1 Hypothesis for GM130 mediated Golgi vesiculation.        
(A) During mitosis, phosphorylation of GM130 at S25 precludes p115 
binding and hence prevents COPI vesicle tethering and could lead to 
Golgi vesiculation. (B) Depletion of GM130 could remove the scaffolding 
ability thereby inhibiting COPI vesicle tethering. However the continued 
anterograde transport maintains Golgi structure substantially. (C) Over 
expression of FL GM130 in the depletion background restores the mitotic 







expression of the S25A mutant in the depletion background, though 
restoring the interphase Golgi structure, could prevent mitotic 
phosphorylation and will allow COPI vesicle fusion even during mitosis 




While the possibility of over expressing ShRNA resistant S25A-GM130 
in cells depleted of GM130 will lend further support, the preliminary 
results from the current set of experiments suggest the following 
possibilities.   
Firstly, it is possible that the Cdk 1 mediated phosphorylation of GM130 
at the S25 residue may not have any role in mediating Golgi 
vesiculation. This suggests that the phosphorylation might serve some 
other purpose during mitosis. It has been shown previously that p115-
GM130 interaction is essential for transport through the Golgi (Seemann, 
Jokitalo et al. 2000). It is possible that the mitotic phosphorylation of 
GM130 is merely to ensure that transport processes are suspended for 
the duration of mitosis so as to ensure proper partition of the Golgi. It 
has also been shown previously that GM130 binds to the t-SNARE 
component Syntaxin 5 and the small GTPase Rab1 in a p115 regulated 
manner. It is thus likely that mitotic phosphorylation of GM130 might 
serve to regulate transport during the process of mitosis and have no 
specific role in Golgi vesiculation. 
A second possibility is that the level of depletion of GM130 that was 
observed (approx. 75%) was not sufficient to prevent the protein from 
carrying out its proposed mitotic function of vesiculating the Golgi. This 
may not be the case because at a comparable level of depletion, the 
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Golgi structure in terms of the ribbon architecture was found to be 
disrupted (Puthenveedu, Bachert et al. 2006). A previous report has 
suggested that up to 90% depletion of GM130 in HeLa cells prevented 
GRASP65 localization at the Golgi. The same study suggested that 
depletion of GM130 by up to 90% induced a G phase cell cycle block 
(Kodani and SuÌˆtterlin 2008). In our experiments, NRK cells depleted of 
GM130 did not have any problems in entering and exiting mitosis. It is 
possible that the effect observed by the previous report was specific for 
HeLa cells. 
Finally, it is possible that the cell relies on more than just one pathway to 
achieve mitotic Golgi vesiculation. This is a very attractive possibility 
since it suggests that mitotic phosphorylation of GM130 at S25 is neither 
necessary nor  sufficient to induce Golgi vesiculation and implies that  
there are parallel pathways that might contribute to mitotic Golgi 
vesiculation.  While it is very difficult to speculate on the identity of the 
proteins involved in these parallel pathways, one thing that can be 
inferred is that the proteins in the pathways are phosphorylated by Cdk 
1. Purvalanol A treatment completely abrogated Golgi vesiculation and 
hence Cdk 1 is involved in Golgi vesiculation. An attractive model is that 
Cdk1 might mediate multiple phosphorylation events on Golgi localized 
targets during early prophase. This ensures that the Golgi undergoes 
vesiculation even if one component or pathway is inactivated.  Some of 
the possible candidates in the pathway are the Golgi matrix proteins 
such as GRASP55 and GRASP65. GRASP65 was previously shown to 
have a major role in the first fragmentation event. It is also known to form 
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a complex with GM130 and the complex helps to maintain the Golgi 
ribbon architecture (Puthenveedu, Bachert et al. 2006). When GM130 
was depleted, GRASP65 localization was also affected (Kodani and 
SuÌˆtterlin 2008). Thus it is an interesting possibility that Cdk 1 
phosphorylates GRASP65 (Separately from the Plk1 based 
phosphorylation that mediates the initial fragmentation) to help in mitotic 
Golgi vesiculation. This model of multiple Cdk 1 targets in the Golgi 
underscores the importance that the cell gives to dispersing the Golgi 
apparatus not just from its pericentriolar locale but also from having a 
definite localization during mitosis. This reinforces the idea that the 
mitotic Golgi vesiculation might serve to accurately segregate the Golgi 
apparatus to both daughter cells. With regard to its role in regulating 
mitosis, further work in specifically perturbing Cdk 1 targets in the Golgi 
is necessary to categorically suggest a role for the Golgi structure in 





















5 Conclusion  
 
This study has focussed on understanding the role of Golgi vesiculation 
in mitotic progression in mammalian cells and more specifically the role 
of the Golgi matrix protein GM130 in regulating Golgi vesiculation.  While 
previous studies have relied on in vitro evidence, this study has 
demonstrated in vivo that Cdk 1 based phosphorylation is essential for 
regulating mitotic Golgi vesiculation and mitotic progression in 
mammalian cells. 
 
Previous in vitro studies had shown that the Golgi matrix protein GM130 
is the target of Cdk1 activity and that mitotic phosphorylation by Cdk 1 
regulates GM130 mediated Golgi breakdown. In our study we have 
shown that over expression of either full length or a phosphorylation 
deficient mutant of GM130 was incapable of inducing a block in Golgi 
vesiculation.  Subsequent ShRNA experiments and rescue experiments 
showed that perturbing GM130 did not affect Golgi vesiculation or 
mitosis lending support to the idea that that Cdk 1 based 
phosphorylation of GM130 might not be the sole pathway that is 
responsible for Golgi breakdown during mitosis. Future work has to 
focus on identifying the Golgi localized targets of Cdk 1 that might act 









Acharya, U., A. Mallabiabarrena, et al. (1998). "Signaling via mitogen-
activated protein kinase kinase (MEK1) is required for Golgi 
fragmentation during mitosis." Cell 92(2): 183-192. 
Allan, B. B., B. D. Moyer, et al. (2000). "Rab1 recruitment of p115 into a cis-
SNARE complex: Programming budding COPII vesicles for fusion." 
Science 289(5478): 444-448. 
Balasubramanian, M. K., E. Bi, et al. (2004). "Comparative analysis of 
cytokinesis in budding yeast, fission yeast and animal cells." Current 
Biology 14(18). 
Colanzi, A., C. H. Carcedo, et al. (2007). "The Golgi mitotic checkpoint is 
controlled by BARS-dependent fission of the Golgi ribbon into separate 
stacks in G2." EMBO Journal 26(10): 2465-2476. 
Colanzi, A. and D. Corda (2007). "Mitosis controls the Golgi and the Golgi 
controls mitosis." Current Opinion in Cell Biology 19(4): 386-393. 
Colanzi, A., C. Suetterlin, et al. (2003). "Cell-cycle-specific Golgi 
fragmentation: How and why?" Current Opinion in Cell Biology 15(4): 
462-467. 
Cole, N. B., N. Sciaky, et al. (1996). "Golgi dispersal during microtubule 
disruption: Regeneration of Golgi stacks at peripheral endoplasmic 
reticulum exit sites." Molecular Biology of the Cell 7(4): 631-650. 
Collins, R. N. and G. Warren (1992). "Sphingolipid transport in mitotic HeLa 
cells." Journal of Biological Chemistry 267(34): 24906-24911. 
Corthesy-Theulaz, I., A. Pauloin, et al. (1992). "Cytoplasmic dynein 
participates in the centrosomal localization of the Golgi complex." 
Journal of Cell Biology 118(6): 1333-1345. 
Feinstein, T. N. and A. D. Linstedt (2007). "Mitogen-activated protein kinase 
kinase 1-dependent golgi unlinking occurs in G2 phase and promotes 
the G2/M cell cycle transition." Molecular Biology of the Cell 18(2): 594-
604. 
Hu, C. K., M. Coughlin, et al. (2008). "Cell polarization during monopolar 
cytokinesis." Journal of Cell Biology 181(2): 195-202. 
Kodani, A. and C. SuÌˆtterlin (2008). "The Golgi protein GM130 regulates 
centrosome morphology and function." Molecular Biology of the Cell 
19(2): 745-753. 
Linstedt, A. D. and H. P. Hauri (1993). "Giantin, a novel conserved Golgi 
membrane protein containing a cytoplasmic domain of at least 350 
kDa." Molecular Biology of the Cell 4(7): 679-693. 
45 
 
Lowe, M. and F. A. Barr (2007). "Inheritance and biogenesis of organelles in 
the secretory pathway." Nature Reviews Molecular Cell Biology 8(6): 
429-439. 
Lowe, M., N. K. Gonatas, et al. (2000). "The mitotic phosphorylation cycle of 
the cis-Golgi matrix protein GM130." Journal of Cell Biology 149(2): 
341-356. 
Lowe, M., C. Rabouille, et al. (1998). "Cdc2 kinase directly phosphorylates the 
cis-Golgi matrix protein GM130 and is required for Golgi fragmentation 
in mitosis." Cell 94(6): 783-793. 
Lowe, M., C. Rabouille, et al. (1998). "Cdc2 kinase directly phosphorylates the 
cis-Golgi matrix protein GM130 and is required for Golgi fragmentation 
in mitosis." Cell 94(6): 783-793. 
Lucocq, J., E. G. Berger, et al. (1989). "Mitotic Golgi fragments in HeLa cells 
and their role in the reassembly pathway." Journal of Cell Biology 
109(2): 463-474. 
Lucocq, J. M., J. G. Pryde, et al. (1987). "A mitotic form of the Golgi apparatus 
in HeLa cells." Journal of Cell Biology 104(4): 865-874. 
Lucocq, J. M. and G. Warren (1987). "Fragmentation and partitioning of the 
Golgi apparatus during mitosis in HeLa cells." EMBO Journal 6(11): 
3239-3246. 
MartÃ-nez-MenÃ¡rguez, J. A., R. Prekeris, et al. (2001). "Peri-Golgi vesicles 
contain retrograde but not anterograde proteins consistent with the 
cisternal progression model of intra-Golgi transport." Journal of Cell 
Biology 155(7): 1213-1224. 
Mellman, I. and K. Simons (1992). "The Golgi complex: In vitro veritas?" Cell 
68(5): 829-840. 
Misteli, T. and G. Warren (1994). "COP-coated vesicles are involved in the 
mitotic fragmentation of Golgi stacks in a cell-free system." Journal of 
Cell Biology 125(2): 269-282. 
Misteli, T. and G. Warren (1995). "Mitotic disassembly of the Golgi apparatus 
in vivo." Journal of Cell Science 108(7): 2715-2727. 
Misteli, T. and G. Warren (1995). "A role for tubular networks and a COP I-
independent pathway in the mitotic fragmentation of Golgi stacks in a 
cell-free system." Journal of Cell Biology 130(5): 1027-1039. 
Moyer, B. D., B. B. Allan, et al. (2001). "Rab1 interaction with a GM130 




Nakamura, N., M. Lowe, et al. (1997). "The vesicle docking protein p115 binds 
GM130, a cis-Golgi matrix protein, in a mitotically regulated manner." 
Cell 89(3): 445-455. 
Nakamura, N., C. Rabouille, et al. (1995). "Characterization of a cis-Golgi 
matrix protein, GM130." Journal of Cell Biology 131(6 II): 1715-1726. 
Nebenfuhr, A., J. A. Frohlick, et al. (2000). "Redistribution of Golgi stacks and 
other organelles during mitosis and cytokinesis in plant cells." Plant 
Physiology 124(1): 135-151. 
Nigg, E. A. (2001). "Mitotic kinases as regulators of cell division and its 
checkpoints." Nature Reviews Molecular Cell Biology 2(1): 21-32. 
Nobes, C. D. and A. Hall (1999). "Rho GTPases control polarity, protrusion, 
and adhesion during cell movement." Journal of Cell Biology 144(6): 
1235-1244. 
Pecot, M. Y. and V. Malhotra (2004). "Golgi Membranes Remain Segregated 
from the Endoplasmic Reticulum during Mitosis in Mammalian Cells." 
Cell 116(1): 99-107. 
Preisinger, C., R. KoÌˆrner, et al. (2005). "Plk1 docking to GRASP65 
phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint 
signalling." EMBO Journal 24(4): 753-765. 
Puthenveedu, M. A., C. Bachert, et al. (2006). "GM130 and GRASP65-
dependent lateral cisternal fusion allows uniform Golgi-enzyme 
distribution." Nature Cell Biology 8(3): 238-248. 
Rivero, S., J. Cardenas, et al. (2009). "Microtubule nucleation at the cis-side 
of the Golgi apparatus requires AKAP450 and GM130." EMBO Journal. 
SÃ¶nnichsen, B., R. Watson, et al. (1996). "Sorting by COP I-coated vesicles 
under interphase and mitotic conditions." Journal of Cell Biology 
134(6): 1411-1425. 
Sandoval, I. V., J. S. Bonifacino, et al. (1984). "Role of microtubules in the 
organization and localization of the Golgi apparatus." Journal of Cell 
Biology 99(1 II): 113S-118S. 
Seemann, J., E. J. Jokitalo, et al. (2000). "The role of the tethering proteins 
p115 and GM130 in transport through the Golgi apparatus in vivo." 
Molecular Biology of the Cell 11(2): 635-645. 
Seemann, J., M. Pypaert, et al. (2002). "Partitioning of the matrix fraction of 




Shah, M., K. Patel, et al. (2005). "Monocrotaline pyrrole-induced endothelial 
cell megalocytosis involves a Golgi blockade mechanism." American 
Journal of Physiology - Cell Physiology 288(4 57-4): C850-C862. 
Shaul, Y. D. and R. Seger (2006). "ERK1c regulates Golgi fragmentation 
during mitosis." Journal of Cell Biology 172(6): 885-897. 
Shima, D. T., N. Cabrera-Poch, et al. (1998). "An ordered inheritance strategy 
for the Golgi apparatus: Visualization of mitotic disassembly reveals a 
role for the mitotic spindle." Journal of Cell Biology 141(4): 955-966. 
Shima, D. T., K. Haldar, et al. (1997). "Partitioning of the Golgi apparatus 
during mitosis in living HeLa cells." Journal of Cell Biology 137(6): 
1211-1228. 
Stuart, R. A., D. Mackay, et al. (1993). "Inhibition of intra-Golgi transport in 
vitro by mitotic kinase." Journal of Biological Chemistry 268(6): 4050-
4054. 
Sutterlin, C., P. Hsu, et al. (2002). "Fragmentation and dispersal of the 
pericentriolar Golgi complex is required for entry into mitosis in 
mammalian cells." Cell 109(3): 359-369. 
Tan, S. Y. and J. Brown (2006). "Rudolph Virchow (1821-1902): "pope of 
pathology"." Singapore medical journal. 47(7): 567-568. 
Thyberg, J. and S. Moskalewski (1999). "Role of microtubules in the 
organization of the Golgi complex." Experimental Cell Research 246(2): 
263-279. 
Turner, J. R. and A. M. Tartakoff (1989). "The response of the Golgi complex 
to microtubule alterations: The roles of metabolic energy and 
membrane traffic in Golgi complex organization." Journal of Cell 
Biology 109(5): 2081-2088. 
Villerbu, N., A. M. Gaben, et al. (2002). "Cellular effects of purvalanol A: A 
specific inhibitor of cyclin-dependent kinase activities." International 
Journal of Cancer 97(6): 761-769. 
Wang, Y., A. Satoh, et al. (2005). "Mapping the functional domains of the 
Golgi stacking factor GRASP65." Journal of Biological Chemistry 
280(6): 4921-4928. 
Warren, G., T. Levine, et al. (1995). "Mitotic disassembly of the mammalian 
Golgi apparatus." Trends in Cell Biology 5(11): 413-416. 
Waters, M. G., D. O. Clary, et al. (1992). "A novel 115-kD peripheral 
membrane protein is required for intercisternal transport in the Golgi 
stack." Journal of Cell Biology 118(5): 1015-1026. 
48 
 
Yoshimura, S. I., K. Yoshioka, et al. (2005). "Convergence of cell cycle 
regulation and growth factor signals on GRASP65." Journal of 
























0.25% trypsin (GIBCO) 10ml 
Hank’s balanced salt solution 40ml 
 (HBBS, GIBCO) 
 
STE (Per L) 
 
NaCl       150 mM 
Tris·HCl (pH 8.0)   44 mM 
Tris-Base  6 mM 
EDTA (pH 8.0)   1 mM 
 
PBS (per L) 
NaCl      80g 
Na2HPO4.7H2O    22g 
KCl      2g 
KH2PO4     2g   
 
